Professional Documents
Culture Documents
Tocolytics
Agents that inhibit uterine contractions
Decreases the uterine motility
Uses
To delay or prevent the premature labor.
The primary goal is to maintain pregnancy for at least
48hrs to enable administration of corticosteroids for
lung maturity
More recently magnesium sulfate for neuroprotection
Possibly maternal transport to tertiary care facility
Contraindications
ruptured membranes
fetus older than 34 WOG
has IUGR
antepartum hemorrhage
eclampsia or severe pre eclampsia
chorioamnionitis
IUFD
CLASSIFICATION
1. Adrenergic Agonists
Salbutamol
Terbutaline
Ritodrine
3. Magnesium Sulphate
4. Cyclo-oxygenase Inhibitors
Indomethacin
5. Oxytocin Antagonists
Atosiban
ADRENERGIC AGONISTS
• Terbutaline
• Salbutamol
• Ritodrine
Mechanism of action
Category C drug
Pharmacokinetic
•Subcutaneous injection
of 0.25mg every 3 to 4 hrs
Category C drug
Dose
Oral 2mg
Maximum dose upto 10mg
Isoxsuprine
Category B drug
Dose
Given by IV infusion, 50 mcg/min and is
increased by 50 mcg every 10 min until
contractions cease
Infusion continued for about 12 hrs after contraction
cease.
10mg per oral 30min prior to stopping IV
medication followed by 10mg per oral every 2hour
or 20mg per oral every 4hour for 24hours.
If stable reduce dose to 10-20mg every 4-6hours
Maximum dose 120mg/day
Adverse Effects of Adrenergic
Agonists
Maternal
headache,
palpitation, tachycardia,
pulmonary edema, cardiac failure,
hyperglycemia, hyperinsulinemia,
lactic acidemia ,
hypokalemia and even death
Fetal
Tachycardia,
Heart failure,
Intra uterine fetal death
Neonatal
Hypoglycemia and
Intraventricular hemorrhage,
Contraindication
Diabetic Mother
Heart Disease
Receiving beta blockers
Calcium Channel Blockers
Nifedipine
Category B drug
Uterine relaxation
Dose
Oral 20 mg followed by 20 mg after half an hour.
Once the contraction stop, it is given in a dose of
10-20mg TID/QID for 48 hours.
Adverse Effects
Maternal
Hypotension
Tachycardia
Headache
Flushing
Nausea
GI reflux
Fetal
Fetal hypoxia due to reduced placental perfusion
Magnesium Sulphate
Category A drug
Pharmacokinetics
- Onset : Immediately IV
- Duration of action : 30 min
- Elimination : urine
Mechanism of action
Antidote
Injection Calcium Gluconate 10% 10
ml IV in 10mins.
Adverse Effects
Maternal
Flushing,
perspiration,
headache,
Muscle weakness and
Pulmonary edema (rare)
Fetal
Skeletal Demineralization,
Hypocalcemia and
Hyper magnesia
Neonates
Lethargy,
Hypotonia,
Skeletal abnormalities
Contraindications
Indomethacin
Category C Drug
Mechanism of action
Contraindications
Active peptic ulcer,
Hepatic disease,
Coagulation disorders
Oxytocin
AtosibanAntagonists
Mechanism of action
Blocks the myometrial oxytocin receptors
Inhibits intracellular calcium release, (release of
PG)
Inhibits myometrial contraction
Maternal side effects
nausea,
vomiting,
headache,
allergic reaction.
Dosing
IV infusion 300 mcg/min (Initial bolus may
be needed)
Thank You